SAN DIEGO, CA, IT&E International Group (ITER), today announced that Gene Resnick, MD has been appointed Vice President, Chief Medical Officer as the company joins with Millennix, Inc. to form the next generation CRO (Clinical Research Organization). Peter Sollenne, IT&E International Group CEO, said, “Dr. Resnick is a recognized expert in drug development, oncology, and regulatory strategy. He brings hands-on experience to IT&E from his duties as President and CEO of Millennix, Inc., acquired in December 2005. The combined entity gives IT&E/Millennix a unique service capability that spans the drug development process from Phase I – IV clinical trials to international regulatory compliance and validation services.”
Dr. Resnick received his Bachelor of Science and Doctor of Medicine degrees at New York Hospital-Cornell, specializing in oncology/medicine practice clinical trials. Earlier, he served in a variety of leadership capacities at Schering-Plough Research Institute as Vice President, Oncology, and supervised global programs with varied therapeutics and indications.

About IT&E International Group

IT&E focuses on providing leading pharmaceutical companies with project-based consulting services in the areas of FDA Regulatory Compliance, data management, biometrics and clinical validation throughout the clinical trials lifecycle. The company, with its talented team of industry veterans with many years of biopharma experience, utilizes the latest tools and procedures to help its clients move quickly and effectively through the FDA approval process. Its services range from providing patients for drug trials, skilled personnel for trials, enterprise software and training to manage data and ensure FDA compliance and validation of new pharmaceutical manufacturing facilities to biostatistics support and analysis, audits, contract research services, data entry and verification services and providing total clinical solutions that take companies completely through Phase IV clinical trials. The company’s pharmaceutical, biotech, healthcare and other life science client list includes such well-known companies as Abbott Laboratories, Amgen, Aventis Pasteur, Baxter Pharmaceutical, Bayer, Bristol-Myers Squibb, Chiron, Eli Lilly, Genentech, GlaxoSmithKline, Novartis, Pfizer, Purdue Pharmaceuticals, Schering-Plough, VaxGen, and Wyeth Global. (